FREE CASE EVALUATION

Prominently Featured In:

CNN
Netflix
Newsweek
Business Insider
Time

What Should I Do When I Receive a DEA or OIG Subpoena

A subpoena from the DEA or the Office of Inspector General is a court order or an administrative demand with legal force. It is not a request. It is not an inquiry. It is a compulsory process that requires a response, and the response requires counsel before it is provided.

The DEA and the OIG issue subpoenas through different mechanisms and under different statutory authorities, but both instruments compel the production of records, testimony, or both from the recipient. A DEA administrative subpoena issued under 21 U.S.C. 876 compels the production of documents and records relevant to a controlled substance investigation. An OIG subpoena issued under the Inspector General Act compels document production in connection with a fraud, waste, or abuse investigation. A grand jury subpoena issued in connection with either agency’s criminal referral is a federal court order compellable through contempt proceedings.

Reading the Subpoena

The first task upon receiving a DEA or OIG subpoena is to read it carefully and completely before taking any other action. The subpoena’s text identifies the issuing authority, the legal basis for the subpoena, the records or testimony demanded, the return date by which compliance is required, and the contact information for the attorney or investigator who issued it. Each of those elements is legally significant.

The return date is the deadline by which the demanded records must be produced or the testimony must be provided. Missing the return date without obtaining an extension can result in a finding of non-compliance and, in the case of a grand jury subpoena, a contempt proceeding. The return date should be identified immediately and calendared as an absolute deadline, while simultaneously recognizing that the period before the deadline is the period for retaining counsel and assessing the appropriate response.

The description of the records demanded defines the scope of the obligation. Records that fall outside the description need not be produced. Records that fall within the description must be produced unless a privilege or other legal protection applies. The boundary between records within and outside the description is often ambiguous, and the resolution of that ambiguity is one of the tasks counsel performs in preparing the response.

Retaining Counsel Before Any Response

No response to a DEA or OIG subpoena should be provided before counsel has reviewed the subpoena and advised on the appropriate course. This instruction applies whether the subpoena requests documents, records, or testimony, and whether the issuing authority is administrative or judicial. The legal consequences of an inadequate response, an over-broad response, or a non-compliant response are each consequential in different ways, and the selection among possible responses requires legal judgment that the recipient cannot exercise without understanding the investigation’s context.

Counsel retained in response to a DEA or OIG subpoena will typically contact the issuing attorney or investigator to obtain background information about the investigation, to request an extension of the return date if the volume or complexity of the demanded records requires additional time to review, and to identify any issues with the subpoena’s scope or legal sufficiency that warrant objection or negotiation.

The contact between counsel and the issuing authority is an information-gathering exercise as much as it is a legal communication. What the attorney or investigator is willing to disclose about the investigation’s subject matter, what they indicate about the practitioner’s status as a witness or target, and what flexibility they express about the subpoena’s scope all inform the strategy for responding to the subpoena and managing the practitioner’s overall exposure.

FREE CONSULTATION

Need Help With Your Case?

Don't face criminal charges alone. Our experienced defense attorneys are ready to fight for your rights and freedom.

  • 100% Confidential
  • Response Within 1 Hour
  • No Obligation Consultation

Or call us directly:

(212) 300-5196

Preserving Records and Avoiding Destruction

From the moment a DEA or OIG subpoena is received, the recipient is on formal notice of a government investigation, and the obligation to preserve all records potentially relevant to that investigation is immediate and comprehensive. The preservation obligation extends beyond the records specifically demanded in the subpoena to all records that a person in the recipient’s position would reasonably understand to be relevant to the investigation.

Routine document retention policies that would otherwise authorize the destruction of records on a scheduled basis must be suspended immediately upon receipt of the subpoena. The destruction of records after receipt of a subpoena, even pursuant to a pre-existing retention policy, can constitute obstruction of justice and creates criminal exposure that is independent of whatever the investigation concerns.

The preservation obligation should be communicated to all personnel who manage records, including electronic records, email systems, and any cloud-based storage used by the practice. A litigation hold notice, prepared by counsel and distributed to relevant personnel, is the standard mechanism for ensuring that the preservation obligation is understood and implemented.

Privilege Review

Before any records are produced in response to a DEA or OIG subpoena, the records must be reviewed for applicable privileges. Attorney-client communications are privileged. Documents prepared in anticipation of litigation under the work product doctrine may be protected. In healthcare matters, the federal medical records privacy protections under HIPAA apply, though HIPAA includes exceptions that permit disclosure in response to certain law enforcement requests and court orders.

Todd Spodek
DEFENSE TEAM SPOTLIGHT

Todd Spodek

Lead Attorney & Founder

Featured on Netflix's "Inventing Anna," Todd Spodek brings decades of high-stakes criminal defense experience. His aggressive approach has secured dismissals and acquittals in cases others deemed unwinnable.

NY Bar Admitted Multi-State Licensed Federal Courts
Meet the Full Team

The records produced in response to a subpoena cannot be recalled. The privilege that was not asserted because the records were produced without review is a privilege that no longer exists. The deadline pressure that a subpoena creates is real, but it is also the mechanism by which subpoenas are sometimes used to induce hasty production that the recipient would have handled differently with more time. The extension request that buys that time is the first task of counsel retained to manage the response.

The Production

The records produced in response to a DEA or OIG subpoena should be accompanied by a cover letter that identifies the production, notes any limitations on the scope of the production, identifies categories of records withheld on privilege grounds, and preserves the recipient’s right to assert objections not included in the cover letter. The cover letter is the production’s documentary record, and it establishes the basis for any subsequent challenge to the government’s use of the produced materials.

Production should be made in the format specified by the subpoena or agreed upon with the issuing authority. Electronic records should be produced in a format that preserves their metadata, which may be relevant to questions about when records were created, modified, or accessed. The production that strips metadata from electronic records, whether intentionally or through inadequate attention to the technical requirements of the production format, may be characterized as an inadequate response.

Share This Article:
Todd Spodek
ABOUT THE AUTHOR

Todd Spodek

Managing Partner

With decades of experience in high-stakes federal criminal defense, Todd Spodek has built a reputation for aggressive, strategic representation. Featured on Netflix's "Inventing Anna," he has successfully defended clients facing federal charges, white-collar allegations, and complex criminal cases in federal courts nationwide.

Bar Admissions: New York State Bar New Jersey State Bar U.S. District Court, SDNY U.S. District Court, EDNY
View Attorney Profile

Community Discussion

Real questions and discussions from readers about this topic.

57
FF former_fed_investigator Former Federal Agent 2w ago

Former investigator perspective on this topic

Retired DEA diversion investigator here. Spent 22 years on the enforcement side. Reading this article and the comments — I want to offer some perspective from the other side of the table.

Most investigations start with data, not complaints. PDMP data, Medicare billing data, pharmacy purchasing records. By the time an agent contacts you, they've usually been looking at your numbers for months. That's why having good documentation matters — the data will flag you, but the documentation either explains the data or doesn't.

65
FF former_fed_investigator Former Federal Agent 2w ago

Talking. Hands down. Doctors who talked to agents without a lawyer — trying to explain their way out of it — gave us 80% of the evidence we needed. Every single time. Get a lawyer first. Always.

48
HD healthcare_defense_atty Attorney 2w ago

Seconding this emphatically. I've represented dozens of healthcare providers. The ones who called me BEFORE talking to agents had dramatically better outcomes than the ones who called AFTER. It's not about having something to hide — it's about having your rights protected from the start.

38
AD anxious_doc_2025 Physician 2w ago

This is incredibly valuable perspective. Can you share — what's the single biggest mistake you saw doctors make when they first learned they were being investigated?

53
WP worried_physician DO 2w ago

Going through exactly what this article describes — anyone else?

Just read this article about "What Should I Do When I Receive a DEA or OIG Subpoena" and it hit close to home. I'm a internal medicine doctor and I've been losing sleep over this. A colleague in my practice group just got investigated. I haven't been contacted directly by any agency yet but the anxiety is crushing. Anyone been through something similar?

54
HD healthcare_defense_atty Attorney 2w ago

First: do NOT speak to any federal agent without counsel. Period. Not the DEA, not the OIG, not the FBI. You have the right to counsel and exercising that right cannot be held against you.

Second: get a consultation NOW, before anything formal happens. Pre-investigation counsel is dramatically more effective (and less expensive) than post-indictment defense. Many healthcare fraud defense attorneys offer free initial consultations.

Third: do NOT alter any records. Do NOT destroy any documents. Do NOT discuss this with staff beyond what's necessary for patient care. Any of those actions can become separate criminal charges (obstruction, evidence tampering) even if the underlying prescribing was entirely legitimate.

38
SI survived_investigation Physician — Investigated & Cleared 2w ago

Went through a DEA investigation 3 years ago. It was the worst 18 months of my life but I came out clean. Best advice: get a lawyer who specifically handles federal healthcare cases (not a general criminal attorney), follow their instructions to the letter, and keep practicing medicine. The investigation itself is not a conviction and most of your patients still need you.

19
PC pharma_compliance PharmD 2w ago

If you haven't already, start documenting everything meticulously going forward. Every prescribing decision should have clear clinical justification in the chart. This protects you regardless of whether an investigation materializes.

34
WW worried_wife_2025 1w ago

My husband is a doctor and I’m terrified after reading this

My wife is a psychiatrist and we just learned the practice is being looked at by the DEA. We have everything tied up in the practice. I don't know anything about criminal defense. How do we even start? How much does this cost? Can they take our house?

51
HD healthcare_defense_atty Attorney 1w ago

I understand the fear. Here's what you need to know:

1. Attorney fees: Federal healthcare fraud defense typically costs $15,000-50,000 depending on the stage and complexity. Pre-investigation work is on the lower end.

2. Your home: In most states, homestead exemptions protect your primary residence. Federal forfeiture requires a direct connection between the property and the alleged criminal activity — simply being a doctor who's investigated doesn't put your house at risk.

3. First step: Call a federal healthcare fraud defense attorney this week. Not a general lawyer. Someone who has handled DEA/OIG cases before. Most will do a free phone consultation to assess the situation.

4. Don't panic: Investigation ≠ charges. Charges ≠ conviction. Many investigations are closed without action.

27
BT been_there_doc 1w ago

I'm the spouse of a physician who went through a 2-year DEA investigation. It was resolved favorably. The emotional toll is real — please consider therapy for both of you. We found a support group for medical professionals under investigation that helped enormously. You're not alone in this.

29
IP independent_pharmacist Pharmacy Owner 3w ago

Pharmacist perspective on “What Should I Do When I Receive a DEA or OIG Subpo”

Running an independent pharmacy and this topic affects us directly. We're getting pressure from both sides — the DEA says we should be gatekeepers, but patients and doctors push back when we question prescriptions. It feels like there's no right answer sometimes. Any other pharmacists dealing with this?

32
PA pharma_attorney Attorney 2w ago

Pharmacists are increasingly being named in federal healthcare fraud cases. Your documentation is your shield. Invest in a compliance program if you don't have one — it's far cheaper than a defense. And know that you DO have the right to refuse to fill prescriptions you believe are not for a legitimate medical purpose. That right is explicitly recognized in federal regulation.

24
FP fellow_pharmacist PharmD 3w ago

You're not alone. The "corresponding responsibility" doctrine puts us in an impossible position. Document EVERYTHING — every conversation with a prescriber about a questionable script, every refusal, every verification call. If you have a compliance program, follow it religiously. If you don't have one, get one yesterday.

28
KC ketamine_clinic_owner Ketamine Provider 1w ago

Anyone running a ketamine clinic dealing with these issues?

I operate a IV ketamine practice and the regulatory landscape feels like it changes monthly. My state medical board issued new ketamine prescribing guidelines. How are other ketamine providers navigating this?

33
HD healthcare_defense_atty Attorney 1w ago

Ketamine clinics are an emerging enforcement target. The Schedule III classification gives you more flexibility than Schedule II, but the "legitimate medical purpose" standard still applies. The biggest risk areas I see: (1) inadequate patient screening, (2) lack of follow-up care, (3) advertising that makes medical claims beyond what's supported, (4) corporate practice of medicine violations if non-physicians have ownership stakes. Get a compliance review done proactively.

26
FK fellow_ketamine_doc Anesthesiologist 1w ago

Running a ketamine clinic since 2021. The key is airtight protocols and documentation. We have:
- Written treatment protocols for every indication
- Informed consent that specifically addresses off-label use
- Pre-treatment screening including psychological evaluation
- Monitoring during and after infusion
- Follow-up documentation
- Clear exclusion criteria

The DEA has been more interested in compounding pharmacies than individual clinics so far, but that could change. Stay current with ASA and APA guidelines.

21
AM anonymous_medical_staff Practice Administrator 3w ago

What should clinic staff know about this topic?

I'm a practice manager at a family medicine office. After reading about "What Should I Do When I Receive a DEA or" — what should front-line staff (receptionists, medical assistants, billing staff) know? We want to make sure we're not inadvertently creating problems. Should we be training staff differently?

20
CO compliance_officer_RN Compliance 3w ago

Key things for staff:

1. Never alter medical records after the fact for any reason
2. If a federal agent shows up, be polite but say "I need to contact our attorney before providing any information"
3. Don't discuss patient cases with anyone outside the practice
4. Follow your office's prescription verification protocol exactly — no shortcuts
5. Document any patient behavior that seems concerning (doctor shopping, lost prescriptions, etc.)

Annual compliance training for all staff is worth every penny.

20
PW PA_worried_about_DEA Nurse Practitioner 1w ago

Does this apply to NPs and PAs too, or just physicians?

I'm a physician assistant with prescriptive authority. Does what this article discusses about "What Should I Do When I Receive a DEA or" apply equally to mid-level providers? I prescribe Suboxone under my collaborating physician's DEA number. If something goes wrong, who is at risk — me, the supervising physician, or both?

37
FM fed_med_lawyer Attorney 1w ago

Both. If you have your own DEA registration, you bear independent responsibility for your prescribing. If you're prescribing under a collaborating physician's DEA number, the supervising physician also has exposure. The DEA does not limit investigations to physicians — NPs, PAs, dentists, podiatrists, and veterinarians have all been targets of federal prescribing investigations.

The same standard applies: prescriptions must be issued for a legitimate medical purpose in the usual course of professional practice. Document your clinical reasoning for every controlled substance prescription.

15
FM fellow_midlevel NP 1w ago

I got my own DEA number specifically so I wouldn't be dragged into my collaborating physician's issues. Worth considering if you haven't already. It also makes your prescribing cleaner from a documentation standpoint.

17
PA podiatrist_anon DPM 1mo ago

Does this apply to podiatrists too?

I'm a podiatrist who prescribes controlled substances. Most of the articles I see focus on physicians and pain management. Are dentists really at risk for DEA scrutiny?

21
FM fed_med_lawyer Attorney 1mo ago

Yes. Any DEA registrant who prescribes controlled substances is subject to the same federal standards. Dentists are increasingly scrutinized for opioid prescribing — the CDC's prescribing guidelines have been applied to dental practice. Veterinarians have seen a rise in diversion cases (drugs prescribed for animals being diverted to human use). The DEA does not distinguish by specialty — they look at prescribing patterns and whether they're consistent with legitimate medical practice.

Ask the Community

Federal Lawyers By The Numbers

36 Cases Handled This Year and counting
15,536+ Total Clients Served since 2005
95% Case Success Rate dismissals & reduced charges
50+ Years Combined Experience in criminal defense

Data as of February 2026

URGENT

Take Control of Your Situation

Our team is standing by to discuss your legal options

Get Advice From An Experienced Criminal Defense Lawyer

All You Have To Do Is Call (212) 300-5196 To Receive Your Free Case Evaluation.